To study the role of XRCC4 in the response to cisplatin in ovarian cancer cells, we stably knocked down XRCC4 using two distinct shRNA clones in both the A2780cisR and SKOV3cisR cell lines. Here, XRCC4 is linked to ovarian carcinoma.